ArticleScientific reports2026
Synergistic antimicrobial potential of Cinnamomum triplinerve essential oils combined with polymyxin B against multidrug-resistant Klebsiella pneumoniae.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance, particularly in carbapenem-polymyxin-resistant Klebsiella pneumoniae (CPR-Kp), is a major global concern. This study evaluated the chemical composition and antimicrobial potential of Cinnamomum triplinerve essential oils against CPR-Kp. Essential oils from leaves (CTL) and bark (CTB) were extracted via hydrodistillation and analyzed by gas chromatography-mass spectrometry. Their antimicrobial activity, alone and combined with polymyxin B (PMB), was assessed through checkerboard assays, biofilm inhibition, cell membrane permeability, and scanning electron microscopy (SEM). Reactive oxygen species (ROS) production was also examined. Safety was evaluated via hemolysis and toxicity tests in Caenorhabditis elegans, which was also used as an infection model to attest combinations in vivo efficacy. (E)-Nerolidol was identified as the major component. CTL and CTB reduced the PMB minimum inhibitory concentration by 32-fold, demonstrating synergy and biofilm inhibition in combination. SEM confirmed bacterial death, though intracellular bacterial protein leakage was absent. CTL-PMB induced oxidative stress, unlike CTB-PMB. No hemolysis or toxicity was observed. Infected C. elegans treated with CTL-PMB and CTB-PMB showed survival rates of 77.77% and 27.29%, respectively. These findings highlight the in vitro and in vivo potential of C. triplinerve essential oils as adjuvants to PMB, offering a promising therapeutic strategy against CPR-Kp infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.